infohep news

• Hepatocellular carcinoma (HCC)

  A healthy lifestyle could prevent most liver cancer and liver-related deaths

  Liz Highleyman / 17 December 2019

  A healthy lifestyle, including smoking cessation, moderate drinking, a balanced diet, exercise and weight loss could dramatically reduce the growing burden of liver cancer and deaths due to liver disease, according to a study ...

• Hepatitis delta

  Combination therapies show promise against hepatitis D

  Liz Highleyman / 16 December 2019

  Combination regimens using lonafarnib or bulevirtide reduced levels of hepatitis delta virus (HDV) in a majority of people with HDV and hepatitis B virus (HBV) co-infection, researchers reported at the AASLD Liver Meeting ...

• Treatment guidelines

  New US guidelines recommend screening of all adults for hepatitis C

  Keith Alcorn / 12 December 2019

  All adults in the United States should be screened for hepatitis C by healthcare providers as part of routine medical care, updated guidelines from the American Association for the Study of Liver ...

• Global burden of deaths and liver cancer due to non-alcoholic fatty liver disease growing

  Keith Alcorn / 11 December 2019

  Non-alcoholic fatty liver disease is a growing cause of liver cancer and death in some regions of the world, an analysis of global reporting on liver disease shows. The findings ...

• Hepatocellular carcinoma (HCC)

  Immunotherapy combination improves liver cancer survival

  Liz Highleyman / 27 November 2019

  A combination of nivolumab (Opdivo) and ipilimumab (Yervoy), two different types of checkpoint inhibitor immunotherapy, led to higher response rates and longer survival than nivolumab alone in people with advanced liver cancer, according to a ...